Barbara Kirkmeyer
- Republican
- Senator
- District 23
The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, any prescription drug that is designated as a drug for a rare disease or condition by the federal food and drug administration. (Note: This summary applies to this bill as introduced.)
No votes to display
Senate Second Reading Laid Over to 05/09/2024 - No Amendments
Senate Second Reading Laid Over to 04/15/2024 - No Amendments
Senate Second Reading Laid Over to 04/08/2024 - No Amendments
Senate Second Reading Laid Over Daily - No Amendments
Senate Second Reading Laid Over to 04/01/2024 - No Amendments
Senate Second Reading Laid Over to 03/18/2024 - No Amendments
Senate Second Reading Laid Over to 03/11/2024 - No Amendments
Senate Committee on State, Veterans, & Military Affairs Refer Unamended to Senate Committee of the Whole
Introduced In Senate - Assigned to State, Veterans, & Military Affairs
Bill Text Versions | Format |
---|---|
Introduced (01/19/2024) | |
Committee Amendment |
Document | Format |
---|---|
Fiscal Note FN1 (01/29/2024) | |
Fiscal Note FN2 (02/09/2024) | |
Fiscal Note FN3 (05/29/2024) |
Data on Open States is updated periodically throughout the day from the official website of the Colorado General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.